|
|
|
||
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
N/A
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
Item 5.03 |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
|
Item 5.07. |
Submission of Matters to a Vote of Security Holders.
|
Nominee
|
Votes For
|
Votes Withheld
|
Broker Non-
Votes
|
|||||||||
Mina Sooch
|
6,595,980
|
162,350
|
4,819,688
|
|||||||||
Cam Gallagher
|
6,555,075
|
193,256
|
4,829,687
|
|||||||||
Sean Ainsworth
|
6,441,608
|
316,723
|
4,819,687
|
|||||||||
James Manuso
|
6,595,074
|
163,457
|
4,819,487
|
|||||||||
Richard Rodgers
|
6,595,181
|
163,150
|
4,819,687
|
|||||||||
Susan Benton
|
6,596,181
|
162,150
|
4,819,687
|
|||||||||
Jay Pepose
|
6,594,974
|
163,357
|
4,819,687
|
Votes For
|
Votes Against
|
Votes Abstain
|
||||||||
11,487,772
|
15,859
|
74,387
|
Exhibit
Number
|
Exhibit Description
|
|
Second Amendment to Second Amended and Restated Bylaws of Ocuphire Pharma, Inc.
|
||
104
|
Cover Page Interactive Data File (embedded within Inline XBRL document).
|
OCUPHIRE PHARMA, INC.
|
||
By:
|
/s/ Mina Sooch
|
|
Mina Sooch
|
||
Chief Executive Officer
|
||
Date: June 17, 2022
|